Whereas an overwhelming number of studies in the last decades have focused on POLD1 pathogenic variants in a wide range of neoplasms, only a few studies have validated the prognostic and predictive utility of POLD1 mRNA and protein expression in human cancers to date. The gene discussed is POLD1; the disease is neoplasm.